Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Neoplasm of Unknown Primary”

108 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 108 results

Early research (Phase 1)Ended earlyNCT00112619
What this trial is testing

Topotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsCarcinoma of Unknown PrimaryLeukemia+2 more
Pediatric Brain Tumor Consortium 19
Early research (Phase 1)Study completedNCT00003548
What this trial is testing

Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity

Who this might be right for
Cancer
NYU Langone Health 20
Testing effectiveness (Phase 2)Study completedNCT04133948
What this trial is testing

Multicenter Phase 1b Trial Testing the Neoadjuvant Combination of Domatinostat, Nivolumab and Ipilimumab in IFN-gamma Signature-low and IFN-gamma Signature-high RECIST 1.1-measurable Stage III Cutaneous or Unknown Primary Melanoma

Who this might be right for
Malignant Melanoma Stage III
The Netherlands Cancer Institute 44
Not applicableStudy completedNCT00477919
What this trial is testing

E-MOSAIC Electronic Tool to Monitor Symptoms

Who this might be right for
Cancer
Swiss Cancer Institute 264
Large-scale testing (Phase 3)UnknownNCT00003558
What this trial is testing

Chemotherapy in Treating Patients With Cancer of Unknown Primary Origin

Who this might be right for
Carcinoma of Unknown Primary
Academisch Ziekenhuis Maastricht 140
Testing effectiveness (Phase 2)Looking for participantsNCT05576974
What this trial is testing

A Phase 2a, Single-dose, Open-label Study to Evaluate Diagnostic Performance and Safety of Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer, in Patients With Unknown Primary Head and Neck Cancer (ILLUMINATE STUDY)

Who this might be right for
Head and Neck CancerUnknown Primary CancerHead and Neck Squamous Cell Carcinoma
University of Texas Southwestern Medical Center 120
Not applicableUnknownNCT04025970
What this trial is testing

Molecular Analysis of Blood Samples in Standardized Cancer Care Referrals for SCAN and CUP

Who this might be right for
Neoplasms, Unknown PrimaryCancer
Christer Ericsson 200
Not applicableUnknownNCT05263700
What this trial is testing

FAPI-CUP- Evaluating FAPI as a Novel Radiopharmaceutical for Cancer of Unknown Primary

Who this might be right for
Cancer of Unknown Primary Site
Peter MacCallum Cancer Centre, Australia 150
Early research (Phase 1)Study completedNCT00014456
What this trial is testing

Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors

Who this might be right for
Bladder CancerBreast CancerCarcinoma of Unknown Primary+9 more
Dartmouth-Hitchcock Medical Center 35
Early research (Phase 1)Looking for participantsNCT07118176
What this trial is testing

Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers

Who this might be right for
Anal CarcinomaBladder CarcinomaBreast Carcinoma+31 more
Jonsson Comprehensive Cancer Center 30
Large-scale testing (Phase 3)UnknownNCT00022178
What this trial is testing

Combination Chemotherapy in Treating Patients With Metastatic Cancer of an Unknown Site of Origin

Who this might be right for
Carcinoma of Unknown Primary
The Christie NHS Foundation Trust
Testing effectiveness (Phase 2)Ended earlyNCT00148135
What this trial is testing

Combination of Carboplatin, Gemcitabine, and Capecitabine in Patients With Carcinoma of Unknown Primary Site

Who this might be right for
Carcinoma of Unknown Primary
University of Michigan Rogel Cancer Center
Large-scale testing (Phase 3)Study completedNCT00047125
What this trial is testing

Radiation Therapy in Treating Patients With Metastases to the Lymph Nodes in the Neck From an Unknown Primary Tumor

Who this might be right for
Carcinoma of Unknown Primary
European Organisation for Research and Treatment of Cancer - EORTC 600
Not applicableActive Not RecruitingNCT04584008
What this trial is testing

Targeted Agent Evaluation in Digestive Cancers in China Based on Molecular Characteristics

Who this might be right for
Biliary Tract NeoplasmsGastric CancerEsophageal Squamous Cell Carcinoma+6 more
Peking University 600
Not applicableLooking for participantsNCT03740503
What this trial is testing

Genomic Investigation of Unusual Responders

Who this might be right for
CancerBreast CancerNon-small Cell Lung Cancer+8 more
University Health Network, Toronto 100
Early research (Phase 1)Study completedNCT00004074
What this trial is testing

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

Who this might be right for
Advanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more
National Cancer Institute (NCI) 15
Not applicableLooking for participantsNCT04504604
What this trial is testing

TCF-001 TRACK (Target Rare Cancer Knowledge) Study

Who this might be right for
Rare CancersCholangiocarcinomaCancer of Unknown Primary Site
TargetCancer Foundation 400
Not applicableNot Yet RecruitingNCT07319949
What this trial is testing

Evaluating the Predictive Capability of Transcriptomic Profiling for Identifying the Primary Site of Metastatic Tumors

Who this might be right for
Malignant Tumor With MetastasisCUP
Fudan University 30
Testing effectiveness (Phase 2)Ended earlyNCT00003526
What this trial is testing

Antineoplaston Therapy in Treating Patients With Cancer of Unknown Primary Origin

Who this might be right for
Unknown Primary Carcinoma
Burzynski Research Institute 8
Not applicableNot Yet RecruitingNCT07372963
What this trial is testing

18F-FAPI PET in Cancers of Unknown Primary Site

Who this might be right for
Cancer of Unknown Primary Site
First Affiliated Hospital of Zhejiang University 120
Load More Results